Skip to main content
. Author manuscript; available in PMC: 2021 Apr 27.
Published in final edited form as: Obesity (Silver Spring). 2020 Oct 3;28(11):2184–2191. doi: 10.1002/oby.22977

Figure 1.

Figure 1.

ANCOVA comparing the membrane capacitance (CM) of women and men with low/no CMD risk (reference groups) to those in groups with increased CMD risk: metabolic syndrome (MetS), insulin resistance (IR), and insulin resistance and metabolic syndrome (IR + MetS). A) Model 1 adjusted for height2and intracellular resistance (RI); and B) Model 2 adjusted for height2, RI, age, African-American race/ethnicity, Mexican American race/ethnicity, DXA lean massǂ, DXA fat massǂ, medication use, smoking, and alcohol use.

Data are expressed as the least-squares adjusted mean ± standard error.

**p < 0.001 versus the low/no-risk group; *** p < 0.0001 versus the low/no-risk

ǂ variable is log-transformed.

Abbreviations: nF, nanoFarads; DXA, Dual-x-ray-absorptiometry.